Startups are raising millions to build businesses around drugs like Ozempic and Wegovy, as they chase a market set to surge to $90 billion.

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...

You can switch from Ozempic® to another medication, but you’ll likely need to start on a low dose of the new medication. Ozempic® is a diabetes drug from the pharmaceutical manufacturer Novo Nordisk.